Aclarion, Inc.

NASDAQ (USD): Aclarion, Inc. (ACON)

Last Price

0.325

Today's Change

-0.003 (0.91%)

Day's Change

0.31 - 0.35

Trading Volume

616,626

Profile
ACON

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Brent Ness Mr. Brent Ness

Full Time Employees:  4 4

IPO Date:  2022-04-22 2022-04-22

CIK:  0001635077 0001635077

ISIN:  US6551872012 US6551872012

CUSIP:  655187102 655187102

Beta:  0.40 0.40

Last Dividend:  0.00 0.00

Dcf Diff:  4.58 4.58

Dcf:  -2.28 -2.28

Description

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Address

951 Mariners Island Boulevard,
San Mateo, CA 94404, US

650-241-1741

http://www.aclarion.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment